ReviewFrontiers in oncology2022

Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers.

Giuliana Cassinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.